Abstract
Background
Evaluation of antibiotic-impregnated (AI) and ionized silver particle coated external ventricular drainage catheters (EVD) in patients with subarachnoid (SAH) or intracranial hemorrhage (ICH).
Methods
Between February 2011 and June 2012, 40 patients with acute hydrocephalus due to SAH, ICH or intraventricular hemorrhage were enrolled in a prospective, randomized, mono-center pilot study. Primary endpoints were defined as: number of events of cerebrospinal fluid (CSF) infections. Secondary endpoints were defined as: neurosurgical complications following the placement of the EVD, number of revisions of EVD catheters, and cost effectiveness.
Results
Sixty-one EVD placements in 40 patients, 32 antibiotic-coated (Bactiseal®), 29 silver-bearing catheters (VentriGuard®), have been performed. Confirmed or high suspicion of CSF infections occurred in 11 out of 61 events (confirmed infection: p = 0.71, probable infection: p = 0.90). Revisions of EVD were needed in 13 cases (22 %) due to CSF infection, dysfunction, impaired healing, or malplacement (p = 0.37).
Conclusion
Regarding CSF infection rate and dysfunction, no statistical significant differences between the two EVD catheters Bactiseal® versus VentriGuard® were found. The silver-bearing catheter might offer a safe and cost-conscious alternative to the AI catheter.
Similar content being viewed by others
References
van Gijn J, Hijdra A, Wijdicks EF, Vermeulen M, van Crevel H. Acute hydrocephalus after aneurysmal subarachnoid hemorrhage. J Neurosurg. 1985;63:355–62.
Hasan D, Vermeulen M, Wijdicks EF, Hijdra A, van Gijn J. Management problems in acute hydrocephalus after subarachnoid hemorrhage. Stroke. 1989;20:747–53.
Woernle CM, Burkhardt JK, Bellut D, Krayenbuehl N, Bertalanffy H. Do iatrogenic factors bias the placement of external ventricular catheters?—a single institute experience and review of the literature. Neurol Med Chir (Tokyo). 2011;51(3):180–6.
Scheithauer S, Burgel U, Ryang YM, Koch S, Schiefer J, Hafner H, Haase G, Lemmen SW. Prospective surveillance of drain-associated meningitis/ventriculitis in a neurosurgery and a neurologic intensive care unit. J Neurol Neurosurg Psychiatry. 2009;80(12):1381–5.
Hoefnagel D, Dammers R, Ter Laak-Poort MP, Avezaat CJ. Risk factors for infections related to external ventricular drainage. Acta Neurochir (Wien). 2008;150:209–14; discussion 214.
Zabramski JM, Whiting D, Darouiche RO, Horner TG, Olson J, Robertson C, Hamilton AJ. Efficacy of antimicrobial-impregnated external ventricular drain catheters: a prospective, randomized, controlled trial. J Neurosurg. 2003;98(4):725–30.
Abla AA, Zabramski JM, Jahnke HK, Fusco D, Nakaji P. Comparison of two antibiotic-impregnated ventricular catheters: a prospective sequential series trial. Neurosurgery. 2011;68(2):437–42; discussion 442.
Pople I, Poon W, Assaker R, Mathieu D, Iantosca M, Wang E, Zhang LW, Leung G, Chumas P, Menei P, Beydon L, Hamilton M, Kamaly I, Lewis S, Ning W, Megerian JT, McGirt MJ, Murphy JA, Michael A, Meling T. Comparison of infection rate with the use of antibiotic-impregnated vs standard extraventricular drainage devices: a prospective, randomized controlled trial. Neurosurgery. 2012;71(1):6–13.
Fichtner J, Güresir E, Seifert V, Raabe A. Efficacy of silver-bearing external ventricular drainage catheters: a retrospective analysis. J Neurosurg. 2010;112(4):840–6.
Lackner P, Beer R, Broessner G, Helbok R, Galiano K, Pleifer C, Pfausler B, Brenneis C, Huck C, Engelhardt K, Obwegeser AA, Schmutzhard E. Efficacy of silver nanoparticles-impregnated external ventricular drain catheters in patients with acute occlusive hydrocephalus. Neurocrit Care. 2008;8(3):360–5.
Keong N, Bulters D, Richards H, Farrington M, Sparrow O, Pickard J, Hutchinson P, Kirkpatrick P. The SILVER (Silver-Impregnated Line Vs EVD Randomized) Trial: a double-blind, prospective, randomized controlled trial of an intervention to reduce the rate of external ventricular drain infection. Neurosurgery. 2012;71(2):394–403; discussion 403–4.
Lozier AP, Sciacca RR, Romagnoli MF, Connolly ES Jr. Ventriculostomy-related infections: a critical review of the literature. Neurosurgery. 2002;51(1):170–81; discussion 181–2.
Le Roux AA, Wallace MC. Outcome and cost of aneurysmal subarachnoid hemorrhage. Neurosurg Clin N Am. 2010;21(2):235–46 (Review).
Lansdown AB. Critical observations on the neurotoxicity of silver. Crit Rev Toxicol. 2007;37(3):237–50.
Maniker AH, Vaynman AY, Karimi RJ, Sabit AO, Holland B. Hemorrhagic complications of external ventricular drainage. Neurosurgery. 2006;59:ONS419–24; discussion ONS24–5.
Saladino A, White JB, Wijdicks EF, Lanzino G. Malplacement of ventricular catheters by neurosurgeons: a single institution experience. Neurocrit Care. 2009;10:248–52.
Acknowledgments
We thank Mrs. M. Winter for her help in the data collection and secretarial work.
Disclosures
The principal investigator initiated study was partially financed by Neuromedex® GmbH, Zollikon, Switzerland, who provided the silver-bearing EVD catheters for free. The authors have no personal or financial or institutional interest in any drugs, materials, or devices described in this article. This study is registered with the national ethic approval (KEK-ZH-Nr: 2010-214).
Author information
Authors and Affiliations
Corresponding author
Additional information
KML Winkler and CM Woernle have contributed equally.
Rights and permissions
About this article
Cite this article
Winkler, K.M.L., Woernle, C.M., Seule, M. et al. Antibiotic-Impregnated Versus Silver-Bearing External Ventricular Drainage Catheters: Preliminary Results in a Randomized Controlled Trial. Neurocrit Care 18, 161–165 (2013). https://doi.org/10.1007/s12028-013-9816-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12028-013-9816-3